SCHEMBL11268852

SCHEMBL11268852

Cc1nc(Cl)cc(NCC(O)c2ccccc2)n1

nearest known ligand 0.51

Predicted protein targets (top 11)

geneUniProtsupporting neighboursconfidence
CYP2D6 P10635 1/20 0.51
FAAH O00519 14/20 0.49
NPC1 O15118 1/20 0.48
RAB9A P51151 1/20 0.48
HTT P42858 1/20 0.48
MEN1 O00255 1/20 0.46
KMT2A Q03164 1/20 0.46
KDM4E B2RXH2 1/20 0.44
L3MBTL1 Q9Y468 1/20 0.44
HPGD P15428 1/20 0.43
MAPK1 P28482 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12322203 1.00 CYP2D6 (0.51) CYP2D6FAAHNPC1RAB9AHTT
SCHEMBL6298554 0.86 CYP2D6 (0.54) CYP2D6FAAHHTTKDM4EL3MBTL1
SCHEMBL12322194 0.83 HRH4 (0.54) CYP2D6FAAHKMT2AKDM4EL3MBTL1
SCHEMBL11280431 0.83 FAAH (0.49) CYP2D6FAAHHTTMEN1KMT2A
SCHEMBL12322218 0.83 FAAH (0.49) CYP2D6FAAHHTTKDM4EL3MBTL1
SCHEMBL3403909 0.80 FAAH (0.55) FAAH
SCHEMBL13663284 0.80 FAAH (0.55) FAAH
SCHEMBL11281707 0.79 ESR1 (0.46) CYP2D6NPC1RAB9AMEN1KMT2A
SCHEMBL6300841 0.78 KDM4E (0.50) CYP2D6FAAHHTTKDM4EL3MBTL1
SCHEMBL3406721 0.77 FAAH (0.68) CYP2D6FAAH

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0004173-B1 2,3-DIHYDROIMIDAZO (1,2-C) PYRIMIDINES, THEIR PREPARATION, FORMULATIONS CONTAINING THEM AND THEIR USE AS PHARMACEUTICALS ELI LILLY AND COMPANY (US) 1982-09-22 EP disclosed
EP-0004173-A1 2,3-Dihydroimidazo (1,2-c) pyrimidines, their preparation, formulations containing them and their use as pharmaceuticals ELI LILLY AND COMPANY (US) 1979-09-19 EP disclosed